Shigemitsu Takashima
Overview
Explore the profile of Shigemitsu Takashima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
1052
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kashiwaba M, Ito Y, Takao S, Doihara H, Rai Y, Kanatani K, et al.
Jpn J Clin Oncol
. 2016 Feb;
46(5):407-14.
PMID: 26917603
Objective: Trastuzumab emtansine significantly improved progression-free survival and overall survival when compared with lapatinib-capecitabine in pretreated human epidermal growth factor receptor 2-positive advanced breast cancer. However, data in Japanese populations...
2.
Aogi K, Rai Y, Ito Y, Masuda N, Watanabe J, Horiguchi J, et al.
Cancer Chemother Pharmacol
. 2013 Mar;
71(6):1427-33.
PMID: 23536163
Purpose: Anthracycline and taxane resistance is a key issue in the treatment of metastatic breast cancer (MBC), particularly in Asian patients who often present with advanced disease. The objective of...
3.
Morimoto T, Tangoku A, Yamakawa T, Tsuruno M, Takashima S
Breast Cancer
. 2013 Mar;
21(4):435-41.
PMID: 23515946
Background: The rate of breast cancer screening in Japan has not increased, and it is thought that one of the reasons is the principle that mammography (MMG) and clinical breast...
4.
Kimura M, Tominaga T, Kimijima I, Takatsuka Y, Takashima S, Nomura Y, et al.
Breast Cancer
. 2012 Sep;
21(3):275-83.
PMID: 22968626
Background: Toremifene, a selective estrogen receptor modulator, is used as adjuvant therapy for postmenopausal patients with breast cancer in Japan. For Japanese patients, however, only limited data are available on...
5.
Hamamoto Y, Ohsumi S, Aogi K, Shinohara S, Nakajima N, Kataoka M, et al.
Breast Cancer
. 2012 May;
21(2):177-82.
PMID: 22569681
Background: To define the factors associated with increased risk of isolated locoregional failure that may justify postmastectomy radiotherapy in patients with T1/2 breast cancer and 1-3 positive lymph nodes. Methods:...
6.
Hamamoto Y, Ohsumi S, Aogi K, Shinohara S, Nakajima N, Kataoka M, et al.
Breast Cancer
. 2012 Mar;
20(3):247-53.
PMID: 22426849
Background: The impact of aggregate of risk factors on isolated locoregional failure after mastectomy without radiotherapy was assessed. Methods: We reviewed 1091 patients who had stage I-III unilateral breast cancer...
7.
Hamamoto Y, Ohsumi S, Aogi K, Takashima S, Shinohara S, Nakajima N, et al.
Breast Cancer
. 2012 Feb;
20(3):218-22.
PMID: 22351124
Background: There is still controversy concerning the indication of postmastectomy radiotherapy (PMRT) for pT3N0M0 breast cancer. To identify the candidates for PMRT in this subset, we investigated failure patterns, and...
8.
Aogi K, Masuda N, Ohno S, Oda T, Iwata H, Kashiwaba M, et al.
Breast Cancer Res Treat
. 2011 Aug;
129(3):829-38.
PMID: 21805309
Unlabelled: Despite extensive evaluation of first-line bevacizumab-containing therapy in randomized trials in locally recurrent/metastatic breast cancer (LR/mBC), data from Japanese populations are limited. We conducted a phase II study exclusively...
9.
Takao S, Tokuda Y, Saeki T, Funai J, Ishii M, Takashima S
Breast Cancer
. 2011 Jul;
19(4):335-42.
PMID: 21751001
Background: Recently gemcitabine has been approved for treatment of metastatic or recurrent breast cancer in Japan; however, no systematically investigated safety study of long-term gemcitabine monotherapy has been reported despite...
10.
Ohsumi S, Inoue T, Kiyoto S, Hara F, Takahashi M, Takabatake D, et al.
Breast Cancer Res Treat
. 2011 May;
130(1):267-72.
PMID: 21590272
Imaging diagnostic methods except for mammograms are not recommended for follow-up of postoperative breast cancer patients in order to detect small recurrences because of the poor survival improvement in earlier...